SEO URLwww.firestrike.ai/deals/imcivree-rhythm-pharmaceuticals-acquisition-2026
acquisitionAnnounced · Jan 9, 2026PharmaceuticalsSource · Unverified ReportsArticle · Factual
Rhythm Pharmaceuticals acquires Imcivree
David Najork · Founding Software Engineer
Announced · Updated · 1 min read
Deal value
—
Target
Imcivree
Acquirer
Rhythm Pharmaceuticals
Status
—
Rhythm Pharmaceuticals agreed to acquire Imcivree. Reported deal value: Undisclosed. Status: Announced. Sector: Pharmaceuticals. Target headquarters context: Location not specified.
This page summarizes publicly available information about the transaction as of 2026-01-09. Figures and status may change as filings and press coverage update.
Shares of Rhythm Pharmaceuticals , Inc. jumped 4% on Friday after the company reported preliminary full-year Imcivree revenue of approximately $194 million, marking a growth of about 50% from FY24
Deal timeline
Announced
Jan 9, 2026 · newsable.asianetnews.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context
This transaction is classified in Pharmaceuticals. Figures and status may change as sources update.
Sources: newsable.asianetnews.com · Primary article · FireStrike proprietary index